Novavax Names Dr. Ruxandra Draghia-Akli as New Executive Vice President and Head of Research Development - StockTitan
| 0A3S Stock | 11.90 3.06 34.62% |
Slightly above 54% of Novavax's private investors are presently thinking to get in. The analysis of overall sentiment of trading Novavax stock suggests that some investors are interested at this time. Novavax's investing sentiment can be driven by a variety of factors including economic data, Novavax's earnings reports, geopolitical events, and overall market trends.
Novavax stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Novavax daily returns and investor perception about the current price of Novavax as well as its diversification or hedging effects on your existing portfolios.
Novavax |
Novavax Names Dr. Ruxandra Draghia-Akli as New Executive Vice President and Head of Research Development StockTitan
Read at news.google.com
 |
Novavax Fundamental Analysis
We analyze Novavax's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Novavax using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Novavax based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Earnings Per Share
Earnings Per Share Comparative Analysis
Novavax is currently under evaluation in earnings per share category among its peers. Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
Novavax Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Novavax stock to make a market-neutral strategy. Peer analysis of Novavax could also be used in its relative valuation, which is a method of valuing Novavax by comparing valuation metrics with similar companies.
Peers
Novavax Related Equities
| GAMA | Gamma Communications | 0.25 | ||||
| 0NIS | SBM Offshore | 0.12 | ||||
| 0P5L | Axway Software | 0.00 | ||||
| NMT | Neometals | 0.00 | ||||
| 0VHI | SilverCrest Metals | 1.83 | ||||
| TIG | Team Internet | 2.59 | ||||
| GRX | GreenX Metals | 4.05 | ||||
| 0QGU | CNH Industrial | 10.44 |
Additional Tools for Novavax Stock Analysis
When running Novavax's price analysis, check to measure Novavax's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novavax is operating at the current time. Most of Novavax's value examination focuses on studying past and present price action to predict the probability of Novavax's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novavax's price. Additionally, you may evaluate how the addition of Novavax to your portfolios can decrease your overall portfolio volatility.